Company Overview of Endeavor Pharmaceuticals, Inc.
As of November 20, 2003, Endeavor Pharmaceuticals, Inc. was acquired by Barr Pharmaceuticals Inc. Endeavor Pharmaceuticals, Inc. operated as a specialty pharmaceutical company, as of June 26, 2002. Its product candidates were designed to alleviate the symptoms of, and reduce the health risks resulting from, menopause-related hormone deficiencies, including hot flashes, osteoporosis, and female sexual dysfunction.
127 Racine Drive
Wilmington, NC 28403
Key Executives for Endeavor Pharmaceuticals, Inc.
Endeavor Pharmaceuticals, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Endeavor Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.